Abstract:
Mono- or diester plasticizers of the formula (I): wherein A is either -OC(0)R' or =0, and X is either -COC(0)R or -C(0)OR, and R and R' are C3 to C13 alkyl, which are the same or different, formed from cyclohexylbenzene and processes of making them.
Abstract:
Process for the preparation of the powdery crystalline mixtures of alpha-hydroxycarbonyl derivatives of alpha-methylstyrene dinners comprising the use of a solvent having polarity from 0 to 0.1.
Abstract:
Die Erfindung betrifft eine Zusammensetzung zur Herstellung optischer Elemente mit Gradientenstruktur, insbesondere für holographische Anwendungen, wobei die Gradientenstruktur durch einen Brechzahlgradienten gebildet wird. Dazu wird eine Zusammensetzung aus einem Polymer und einem licht- und/oder temperaturempfindlichen Metallkomplex hergestellt und der licht- und/oder temperaturempfindliche Metallkomplex unter Änderung des lokalen Brechungsindex zersetzt wird. Dadurch kommt es zur Ausbildung eines Brechzahlengradienten.
Abstract:
The invention relates to small molecules which function as inhibitors of anti-apoptotic Bcl-2 family member proteins (e.g., Bcl-2 and Bcl-xL). The invention also relates to the use of these compounds for inducing apoptotic cell death and sensitizing cells to the induction of apoptotic cell death.
Abstract:
Methods and compositions are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, erectile dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. The invention further discloses methods of making optically pure bupropion metabolites.
Abstract:
Novel trienoic retinoid compounds having activity for retinoic acid receptors and retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such compounds and methods for their use.
Abstract:
Device and methods for use in a biosensor comprising a multisite array of test sites, the device and methods being useful for modulating the binding interactions between a (biomolecular) probe or detection agent and an analyte of interest by modulating the pH or ionic gradient near the electrodes in such biosensor. An electrochemically active agent comprising quinone derivatives that is suitable for use in biological buffers for changing the pH of the biological buffers. Method for changing the pH of biological buffers using the electrochemically active agents. The methods of modulating the binding interactions provided in a biosensor, analytic methods for more accurately controlling and measuring the pH or ionic gradient near the electrodes in such biosensor, and analytic methods for more accurately measuring an analyte of interest in a biological sample.
Abstract:
The present invention relates to compositions, for example, the DBU/Hexafluoroacetone hydrate salt, and processes of preparing and using the same for the modification of chemical compounds via the release of trifluoroacetate. The DBU/Hexafluoroacetone hydrate salt can perform trifluoromethylation reactions on chemical compounds, such as carbonyl group-containing compounds.